EU Evaluation Of FDA District Offices Under MRA To Begin By Feb. 2001
This article was originally published in The Tan Sheet
Executive Summary
FDA expects European regulators to begin assessing agency district offices in the next six to eight months, Office of Regulatory Affairs Regional Director Deborah Ralston told a June 5 Food & Drug Law Institute meeting in Washington, D.C.